Mastocytosis – A Disease of the Hematopoietic Stem Cell
Authors:
- Hans-Peter HornyHHHans-Peter Horny
- Karl SotlarKSKarl Sotlar
- Peter ValentPeter Valent
- Karin HartmannKHKarin Hartmann
- 3 October 2008
- journal article
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 105 (40) , 686-92
Abstract
Mastocytosis is an unusual clonal disease of the hematopoietic stem cell. This article is based on a selective literature search and on the authors' clinical and pathological experience. The clinical manifestations of mastocytosis range from cutaneous mastocytosis, a common, prognostically favorable presentation, to mast cell leukemia, a rare, life-threatening disease. The mediator-induced symptoms usually respond well to H1 antihistamines. Therapeutic standards for cytoreduction in the progressive, systemic forms of mastocytosis are still lacking. Because some of the manifestations of mastocytosis are nonspecific and can be mimicked by other diseases, there is a risk of two types of diagnostic error: Mastocytosis may remain undiagnosed when it is actually present, or it may be diagnosed even though morphological and molecular findings rule out mastocytosis. Well-defined criteria should be used to differentiate mastocytosis from other diseases with a similar clinical presentation.Keywords
This publication has 29 references indexed in Scilit:
- UrticariaJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2008
- Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patientsAllergy, 2008
- Systemic Mastocytosis Associated with Chronic Idiopathic MyelofibrosisThe Journal of Molecular Diagnostics, 2008
- How we diagnose and treat WHO-defined systemic mastocytosis in adultsHaematologica, 2008
- Mast cells: Versatile regulators of inflammation, tissue remodeling, host defense and homeostasisJournal of Dermatological Science, 2008
- Diagnostic and Subdiagnostic Accumulation of Mast Cells in the Bone Marrow of Patients with Anaphylaxis: Monoclonal Mast Cell Activation SyndromeInternational Archives of Allergy and Immunology, 2006
- Molecular Diagnosis of Mast Cell DisordersThe Journal of Molecular Diagnostics, 2006
- Mastocytosis and Hymenoptera venom allergyCurrent Opinion in Allergy and Clinical Immunology, 2006
- Comparison of azelastine and chlorpheniramine in the treatment of mastocytosisJournal of Allergy and Clinical Immunology, 1993
- Response of Cutaneous Mast Cells to PUVA in Patients with Urticaria Pigmentosa: Histomorphometric, Ultrastructural, and Biochemical InvestigationsJournal of Investigative Dermatology, 1984